Abstract
Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease) remains a challenge for all clinicians, as in about 80% of cases nasal bleeding is the first manifestation of this disease, which is characterized by a clinical triad of multiple telangiectasias, recurrent hemorrhages and familial occurrence. Although in the last few years there has been diagnostic and therapeutic progress, a cure for this rarely life-threatening but often burdening and handicapping disease is still not possible. We have reviewed head and neck presentations, diagnostic and therapeutic features, as well as new insights into the molecular genetics of the disease and local treatment now available.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 11 August 1998 / Accepted: 28 September 1998
Rights and permissions
About this article
Cite this article
Bergler, W., Götte, K. Hereditary hemorrhagic telangiectasias: a challenge for the clinician. European Archives of Oto-Rhino-Laryngology 256, 10–15 (1999). https://doi.org/10.1007/s004050050114
Issue Date:
DOI: https://doi.org/10.1007/s004050050114